$1.06
0.02[1.92%]
Last update: 1:49PM Get Real Time Here
IN8bio Stock (NASDAQ:INAB), Analyst Ratings, Price Targets, Predictions
IN8bio Inc has a consensus price target of $9.79, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Laidlaw & Co., and HC Wainwright & Co. on April 10, 2024, March 18, 2024, and March 15, 2024. With an average price target of $11.83 between HC Wainwright & Co., Laidlaw & Co., and HC Wainwright & Co., there's an implied 1016.35% upside for IN8bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Laidlaw & Co.
JonesTrading
EF Hutton
Mizuho
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for IN8bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | INAB | Buy Now | IN8bio | $1.06 | 607.55% | Laidlaw & Co. | Yale Jen | → $7.5 | Initiates | → Buy | Get Alert |
| 03/15/2024 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | INAB | Buy Now | IN8bio | $1.06 | 371.7% | JonesTrading | Soumit Roy | → $5 | Initiates | → Buy | Get Alert |
| 11/13/2023 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | INAB | Buy Now | IN8bio | $1.06 | 654.72% | EF Hutton | Tony Butler | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/26/2023 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | → Buy | Get Alert |
| 04/24/2023 | INAB | Buy Now | IN8bio | $1.06 | 1032.08% | Mizuho | Mara Goldstein | → $12 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | INAB | Buy Now | IN8bio | $1.06 | 654.72% | EF Hutton | Tony Butler | → $8 | Maintains | Buy | Get Alert |
| 03/31/2023 | INAB | Buy Now | IN8bio | $1.06 | 654.72% | EF Hutton | Tony Butler | → $8 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | INAB | Buy Now | IN8bio | $1.06 | 654.72% | EF Hutton | Tony Butler | → $8 | Initiates | → Buy | Get Alert |
| 11/11/2022 | INAB | Buy Now | IN8bio | $1.06 | 183.02% | B. Riley Securities | Kalpit Patel | $9 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 08/30/2022 | INAB | Buy Now | IN8bio | $1.06 | 1220.75% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Initiates | → Buy | Get Alert |
| 01/24/2022 | INAB | Buy Now | IN8bio | $1.06 | 749.06% | B. Riley Securities | Kalpit Patel | $19 → $9 | Maintains | Buy | Get Alert |
| 08/24/2021 | INAB | Buy Now | IN8bio | $1.06 | 1032.08% | Mizuho | Mara Goldstein | — | Initiates | → Buy | Get Alert |
| 08/23/2021 | INAB | Buy Now | IN8bio | $1.06 | 1692.45% | B. Riley Securities | — | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for IN8bio (INAB)?
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on April 10, 2024. The analyst firm set a price target for $14.00 expecting INAB to rise to within 12 months (a possible 1220.75% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IN8bio (INAB)?
The latest analyst rating for IN8bio (NASDAQ: INAB) was provided by HC Wainwright & Co., and IN8bio reiterated their buy rating.
When was the last upgrade for IN8bio (INAB)?
There is no last upgrade for IN8bio.
When was the last downgrade for IN8bio (INAB)?
The last downgrade for IN8bio Inc happened on November 11, 2022 when B. Riley Securities changed their price target from $9 to $3 for IN8bio Inc.
When is the next analyst rating going to be posted or updated for IN8bio (INAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IN8bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IN8bio was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating IN8bio (INAB) correct?
While ratings are subjective and will change, the latest IN8bio (INAB) rating was a reiterated with a price target of $0.00 to $14.00. The current price IN8bio (INAB) is trading at is $1.06, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.